5Hulten KG, Kaplan SL, Gonzalez BE, et al. Three - year surveillance of community on set health care - associated staphylococcus aureus infection in children[ J]. Pediatr Infect Dis J,2006,25 (4) :349 -353.
6Morozumi M, Iwata S, Hasegawa K, et al. Increased macrolide resistance of mycoplasma pneumonia in pediatric patients with sommunity -acquired pneumonia[ J]. Ntimicrob Agents Chemother,2008,52 ( 1 ) :348 - 350.
10Okazaki N, Narita M, Yamada S, et al. Characteristic of macrolide - resistant Myeoplasma pneumoniae strains isolated from patients and induced with Erythromycin in vitro [ J ]. Microbiol Immunol, 2001,45 (8) :617 -620.
9Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with Erythromycin in Vitro. Microbiol Immunol, 2001,45:617-620.
10Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother, 2004,48:4624-4630.
9Tamura A, Matsubara K, Tanaka T, et al. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children.lnfect, 2008, 57(3):223-228. 2004, 19(60):454.
10Yao KH, Wang LB, Zhao GM, et al.Streptoeoeeus pneumoniae antimierobial resistance and serotype distribution in Chinese children hospitalized for pneumonia. Submitted, 2009,20(9):776-777.
